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Abstract
RNF213/Mysterin has been identified as a susceptibility gene for moyamoya disease, a
cerebrovascular disease characterized by occlusive lesions in the circle of Willis. The p.
R4810K (rs112735431) variant is a founder polymorphism that is strongly associated with
moyamoya disease in East Asia. Many non-p.R4810K rare variants of RNF213 have been
identified in white moyamoya disease patients, although the ethnic mutations have not
been investigated in this population. In the present study, we screened for RNF213 variants
in 19 Slovakian and Czech moyamoya disease patients. A total of 69 RNF213 coding
exons were directly sequenced in 18 probands and one relative who suffered from moya-
moya disease in Slovakia and the Czech Republic. We previously reported one proband
harboring RNF213 p.D4013N. Results from the present study identified four rare variants
other than p.D4013N (p.R4019C, p.E4042K, p.V4146A, and p.W4677L) in four of the
patients. P.V4146A was determined to be a novel de novo mutation, and p.R4019C and p.
E4042K were identified as double mutations inherited on the same allele. P.W4677L, found
in two moyamoya disease patients and an unaffected subject in the same pedigree, was a
rare single nucleotide polymorphism. Functional analysis showed that RNF213 p.D4013N,
p.R4019C and p.V4146A-transfected human umbilical vein endothelial cells displayed sig-
nificant lowered migration, and RNF213 p.V4146A significantly reduced tube formation,
indicating that these are disease-causing mutations. Results from the present study
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identified RNF213 rare variants in 22.2% (4/18 probands) of Slovakian and Czech moya-
moya disease patients, confirming that RNF213 may also be a major causative gene in a
relative large population of white patients.
Introduction
Moyamoya disease (MMD) is a progressive cerebrovascular disease characterized by bilateral
stenoses of the arteries around the circle of Willis with prominent arterial collateral circulation
[1–3]. Recently, RNF213/Mysterin was identified as a susceptibility gene for MMD, and its p.
R4810K variant (rs112735431) has been shown to be a founder polymorphism that is strongly
associated with MMD in East Asia [4,5]. Many RNF213 rare variants other than p.R4810K
have been identified in MMD patients in ethnically diverse populations, including Asians,
whites, and Hispanics, while p.R4810K is absent in non-Asian populations [6]. These reports
highlight the importance of screening for RNF213 rare variants in MMD patients.
In present study, we screenedRNF213 rare variants in 19 white Slovakian and CzechMMD
patients. Results revealed four rare variants, including a novel de novomutation and a haplo-
type carrying two mutations.
Materials and Methods
Patients
Eighteen Slovakian or Czech probands and one relative with MMD (Table 1) were recruited
for this study from 2008 to 2015. Among them, one proband harboring RNF213 p.D4013N
Table 1. Clinical characteristics of Slovak and Czech probands with MMD.
Proband No. ID in present paper Gender Age (year) Onset age (year) Onset type Laterality RNF213 rare variant Reference
1 Male 44 30 CI Bilateral p.D4013N [4]*
2 II-2 Family 1 Female 21 9 TIA Bilateral p.V4146A
3 II-1 Family 2 Female 28 19 CI Bilateral p.R4019C, p.E4042K
4 III-2 Family 3 Female 27 5 paresis Bilateral p.W4677L
mother of 4 II-2 Family 3 Female 48 31 CI Unilateral p.W4677L
5 Female 34 30 CI Bilateral (-)
6 Female 41 18 months TIA Bilateral (-)
7 Female 9 8 TIA Bilateral (-)
8 Female 34 32 CI Bilateral (-)
9 Female 48 44 CI Bilateral (-)
10 Male 47 47 CI Bilateral (-)
11 Female 24 24 headache Unilateral (-)
12 Male 41 40 CI Bilateral (-)
13 Female 22 19 hemiparesis Unilateral (-)
14 Female 19 19 CI Unilateral (-)
15 Female 33 33 CI Bilateral (-)
16 Male 36 36 CI Bilateral (-)
17 Female 39 38 CI Bilateral (-)
18 Female 23 23 dystonia Bilateral (-)
CI, cerebral infarction; TIA, transient cerebral ischemia
*This patient was reported in our previous paper.
doi:10.1371/journal.pone.0164759.t001
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was previously reported by our group [4]. This study was approved by the Institutional Review
Board and Ethics Committee of Kyoto University School of Medicine, Japan (Approval num-
ber:G342; approval date: 12/25/2009) and the Ethics Committee of the University Hospital
Olomouc and Palacký University Faculty of Medicine and Dentistry in Olomouc, Czech
Republic (Approval number: 62/10; approval date: 8/18/2008).
Genetic analysis
Genomic DNA was extracted from peripheral blood using the QIAamp DNA BloodMini Kit
(Qiagen, Hilden, Germany). Direct sequencing was performed on 69 coding exons of RNF213
using previously describedprimers [4]. The amino acid coding was based on AB537889. Hap-
lotype analysis was performed using the microsatellite markers flanking the RNF213 p.V4146A
locus (D17S944, D17S949, D17S785, D17S784, and D17S928). The markers were genotyped
using ABI Prism LinkageMapping Set (Version 2; Applied Biosystems, Foster City, CA, USA).
Cloning
Cloning of the RNF213 exon 43 and 44, including RNF213 p.R4109C and p.E4042K in II-1 in
Family 2 (Fig 1A), was performed to determine the haplotype of the two variants. Genomic
DNA polymerase chain reaction (PCR) was performed using the following primers; ex43F: 50-
TTG GCC CTG AAT GTG GTG CT-30, ex44R: 50-TTC TCT GAG GTC AGG TTT TCT ACC-30.
The PCR product was cloned using the TOPO PCR cloning system (Invitrogen, Carlsbad, CA,
USA). Randomly selected colonies were prepared for sequencing.
Database search for candidate variants
Minor allele frequency (MAF) of variants in the European population was investigated using
two variant databases: the 1000 Genomes Project (http://www.1000genomes.org/) and the
Exome Variant Server (http://evs.gs.washington.edu/EVS/). The effect of the variants on pro-
tein functionwas assayed using two prediction algorithms: Polyphen2 (http:/genetics.bwh.
harvard.edu/pph2) and SIFT (http://sift.bii.a-star.edu.sg/). Variant homologywas determined
using the protein BLAST search engine (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
RNF213 mutant plasmids
RNF213mutant plasmids were produced by mutagenesis with the RNF213WT plasmid, which
was described in our previous study [7]. The p.D4013N, pR4019C or p.V4146A mutation was
introduced by PCR-based site-directedmutagenesis using mutated primers (D4013N-F, 5’-
CTG TCT GCC CTG CAA CCA CGT GCA CTG C-3’; D4013N-R,5’-GCA GGC AGT GCA CGT
GGT TGC AGG GCA G-3’; R4019C-F, 5’-CGT GCA CTG CCT GTG CTG CCT CAG GGC CTG
G-3’; R4019C-R,5’-CCA GGC CCT GAG GCA GCA CAG GCA GTG CAC G-3’; V4146A-F,
5'- CAG CTT TCA TGA TGC AAA AGA TTA TAT TCA GG-3'; V4146A-R, 5’-CCT GAA
TAT AAT CTT TTG CAT CAT GAA AGC TG-3') and Pfu Turbo DNA polymerase (Agilent
Technologies, Santa Clara, CA). The generated constructs were confirmed by sequencing.
Migration and tube formation and assays
Migration and tube formation were assessed as describedpreviously [7]. Briefly, human umbil-
ical vein endothelial cells (HUVECs) (Life Technologies, Carlsbad, CA) were maintained in
Medium 200 with low serum growth supplement (Life Technologies). For migration assays,
the RNF213 (WT, D4013N, R4019C and V4146A) plasmids were transfected into 4x105 cells of
HUVECs using lipofectamine 3000 (Life Technologies) respectively. The transfected cells were
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Fig 1. Identification of RNF213 rare variants in three families. (A) Pedigree chart and genotypes of RNF213 rare variants
and microsatellite markers of the three families. Filled and unfilled symbols indicate affected and unaffected individuals,
respectively. Squares and circles represent males and females, respectively. Arrows indicate index case. (B) Sequence
chromatography of the identified RNF213 rare variants. (C) Haplotype for p.R4019C and p.E4042K determined by cloning in
II-1 in Family 2.
doi:10.1371/journal.pone.0164759.g001
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seeded into culture insert (Ibidi, Germany), and after 12 hours, the insert was removed to test
cell migration. After 8 h incubation, digital images of wound narrowing (re-endothelialization)
were obtained. For tube formation assay, transfectedHUVECs (RNF213WT, D4013N and
V4146A) were seeded onto Geltex LDEV Free matrix (Life Technologies) with μ-slide angio-
genesis (Ibidi), and after 15h incubation digital images of the formed tubes were captured. To
quantify, the area of re-endothelialization (migration assay) or the area and total length of the
tubes, and the number of tube branches (tube formation assay) were calculated using ImageJ
software (National Institutes of Health).
Statistical analysis
Results are presented as mean ± SD. The number of samples is provided in the figure legends.




The clinical characteristics of 19 Slovakian and CzechMMD patents (18 probands and one rel-
ative) are shown in Table 1. In the majority of the 19 examinedMMD patients, clinical mani-
festations included cerebral infarction (63.1%, 12/19) or transient ischemic attack (15.8%, 3/
19), and other clinical symptoms were represented by (hemi)paresis without the development
of cerebral infarction (10.5%, 2/19), headache (5.3%, 1/19), or dystonia (5.3%, 1/19). This was
consistent with the most commonMMDmanifestations. In the present study, no patients suf-
fered from other possible manifestations of MMD, such as intracranial hemorrhage, epileptic
seizures, or cognitive decline. Detailed clinical information from four patients with RNF213
rare variants identified in the present study (Fig 1A) are describedbelow.
II-2 in Family 1 (Fig 1A). A 21-year-old white female was admitted complaining of a
2-day history of headache, visual problems, and right-hand clumsiness in March 2015. Neuro-
logical examination disclosed the presence of severe anomic aphasia, agraphia, semantic mem-
ory deficits, right-sided hemianopsia, and visual alexia. Initial native brain computed
tomography (CT) showed acute cerebral infarction in the left parietal lobe (S1 Fig). Acute cere-
bral ischemia in the left parieto-occipital region was confirmed by diffusion-weighted imaging
magnetic resonance imaging (DWI-MRI) (S2 Fig). Magnetic resonance imaging including
magnetic resonance angiography (MRA) revealed severe steno-occlusive changes in the circle
of Willis and typical basal moyamoya vessels (Fig 2A, S3 Fig). Digital subtraction angiography
(DSA) was used to confirm pathological moyamoya vessels (Fig 2B).
Duplex ultrasound revealed thickening of the carotid bulb in both internal carotid arteries
(ICAs) (S4 Fig). Transcranial color-coded sonography (TCCS) confirmed severe flow reduction
in the intracranial arteries, especially in the left middle cerebral artery (Fig 2C). We did not find
any other laboratory, systemic, or vascular abnormalities, which included diagnosis by CT angi-
ography of the thoracic and abdominal aorta, craniocervical,pulmonary, renal arteries, aorta-
iliac bifurcation, iliac arteries, and the arterial system of the lower extremities. Examination of
the cerebrospinal fluid (CSF) was completely normal. Echocardiography disclosed a small pro-
lapse with insignificant regurgitation of the anterior leaflet of the mitral valve. Because of the
initial suspicion of extracranial and intracranial arteritis, combined immunosuppressive ther-
apy (60 mg prednisone and 100 mg azathioprine daily) was initiated and continued for almost
3 months. Since June 2015, combined antiplatelet therapy (100 mg acetylsalicylic acid and
75 mg clopidogrel daily) was initiated and continues to present. Severe reading difficultiesper-
sist, whichmakes it impossible for the patient to continue with university studies. The patient
RNF213 Rare Variants in Slovakian/Czech MMD Patients
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Fig 2. Imaging data of II-2 in Family 1. (A) MRA image. TOF-3D MRA verifies typical steno-occlusive
changes of the circle of Willis. Distal T segments of both internal carotid arteries are occluded and basal
moyamoya vessels are clearly seen (anteroposterior view, left panel). Typical “puff-of-smoke” look of
moyamoya vessels. Internal carotid arteries are relatively hypoplastic compared with the vertebrobasilar
system (lateral view, right panel). (B) Digital subtraction angiography. Catheterization angiography of left
vertebral artery (left panel), left carotid artery (middle panel), and right carotid artery (right panel). (C)
Transcranial color-coded sonography. Severely dampened flow in the M1 segment of the left middle cerebral
artery.
doi:10.1371/journal.pone.0164759.g002
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also does not tolerate severe physical activity or cold weather, which provoke episodes of sud-
den weakness and the tendency to collapse. RepeatedMRI performed inMay 2015 showed par-
tial dissolution of the previously present DWI positivity, although new small hyperintense
lesions appeared in the parieto-occipital region (S5 Fig). Perfusion CT performed in June 2015
demonstrated a relative cortico-subcorticalhypoperfusionwith decreased cerebral blood flow,
prolonged mean transit time, and time-to-drain values with normalization of cerebral blood
volume, as well as postmalatic lesions in the left parietal and occipital lobes (S6 Fig). Revascular-
ization surgerywas planned for the left hemisphere.
When analyzing the patient’s previous medical history, we discovered repeated collapses
and short periods of muscle tone loss (“drop attacks”), which were initially reported at 9 years
of age. These episodes were provoked by various stimuli (physical activity, cold, and vegetative
discomforts) and were interpreted as epileptic seizures. At 14 years of age, the patient was
admitted to the hospital and MRI was performed. The MRI/MRA images revealed typical find-
ings suggestive of MMD (S7 Fig). However, she was unfortunately not diagnosedwith MMD.
Repeated electroencephalogramsconfirmed epileptiform changes provoked by hyperventi-
lation and photostimulation. Electromyography verified positivity for neurogenic tetania.
Valproate was introduced to the treatment strategy. Headache episodes have beenmentioned
in subsequent years. In June 2014, the patient was admitted to the hospital owing to a sudden
onset of fever accompanied by headache and photophobia. Brain CT and CSF examination
were interpreted as normal. Laboratory tests and serological findings were negative, and echo-
cardiography and abdominal sonography showed normal results.
The patient has three healthy siblings, and both parents are healthy. We performed complex
MRI/MRA and sonographic examinations, including duplex sonography and TCCS in all fam-
ily members without any definite pathological findings.
II-1 in Family 2 (Fig 1A). A white female patient suffered from an acute ischemic stroke
in the right hemisphere presenting with a severe left-sided hemiparesis at the age of 19 years
(S8 Fig). After intensive care and rehabilitation, she is able to walk independently, despite
residual spastic hemiparesis on the left side. Because the patient was trying to plan to get preg-
nant, she underwent a clinical control examination in May, 2015 at the age of 28 years. The
MRA (Fig 3A), DSA (Fig 3B), MRI (S8 Fig), and computed tomography angiography (S9 Fig)
were performed, and patient was diagnosedwith MMD.
II-2 in Family 3 (Fig 1A). A white female suffered from repeated stroke and underwent
extra-intracranial (EC-IC) bypass with encephalo-duro-angio-myo-synangiosis (EDAMS) on
the left side at 31 years of age. She also had a history of arterial hypertension, idiopathic throm-
bocytopenicpurpura, sideropenic anemia, and mild hypercholesterolemia. Repeated percuta-
neous transluminal angioplasty was performed in both renal arteries, the right subclavian
artery, and the mesenteric superior artery between the ages of 38 and 43 years. Cerebral angiog-
raphy, which was performed at 40 years of age, showed left ICA occlusion with collateral blood
flow through the left EC-IC bypass, the anterior communicating artery, and the left posterior
communicating artery, as well as stenosis of the right ICA (in the siphon) and aneurysmatic
dilation of the top of basilar artery (without indication for the endovascular procedure, because
of involvement of both posterior cerebral arteries and both superior cerebellar arteries). Addi-
tionally, mild post-ischemic changes in the right paraventricular localization were found on
brain MRI, which was performed at the same age. One year later, ultrasonographic examina-
tion revealed collateral blood flow to the left cerebral hemisphere and the left ophthalmic
artery, as well as severe stenosis in the renal arteries. The patient only suffered from intermit-
tent headaches during the follow-up period, and her current neurological status is stable.
III-2 in Family 3. A white female, the daughter of the II-2 case, developed severe paresis
of the left lower limb with gradual regression at the age of 5 years (April 1994). Identical
RNF213 Rare Variants in Slovakian/Czech MMD Patients
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symptoms occurred also in June 1994, and brain CT revealed narrower lateral ventricles.
Although she was treated with immunosuppressants (prednisone and azathioprine), repeated
paresis occurred during treatment. The patient was diagnosedwith arterial hypertension. In
December 1994, angiography was performedwith normal findings in the renal arteries but
resulted in a MMD diagnosis. In March 1995, the patient underwent EDAMS surgery on both
sides. In addition to anti-hypertensive medication, anti-platelet therapy was administered. In
May 1996, carotid angiography showed a normal post-operative finding. In March 1997, brain
CT revealedmild asymmetry of the lateral ventricles; echocardiography revealedmild septal
hypertrophy. In January 2000, MRA was performedwith normal findings. Depending on the
actual blood pressure values, the anti-hypertensive therapy was altered accordingly. In June
2006, ultrasonographic examination verifiedMMD (with hypoperfusion in both ICAs, inter-
nalization of perfusion in both external carotid arteries); echocardiography showed normal
findings. Doppler examination of renal arteries was repeated in December 2007 with normal
findings. The patient only suffered from intermittent headaches during the follow-up period;
otherwiseher current neurological status remains stable. History of Idiopathic thrombocytope-
nic purpura was absent.
Identification of RNF213 rare variants
Exon sequencing of RNF213was performed in 18 probands and one relative with MMD.
RNF213 exonic variants found in theseMMD patients were shown in S1 Table. From these
variants, we focus on rare variants whoseMAFs in European general population are less than
or equal to 1.5% (S1 Table), becauseMAF of an East Asian MMD-associated variant, p.
R4810K was approximately 1.5% [4]. As a result, in addition to p.D4013N, which was previ-
ously reported by our group [4], four rare variants were identified in four patients (Table 1, Fig
1A and 1B). A novel variant, RNF213 p.V4146A (T>C), was identified in II-2 of Family 1.
However, direct sequencing in the healthy parents, one sister, and two brothers (I-1, I-2, II-1,
Fig 3. Imaging data of II-1 in Family 2. (A) MRA image at 2015. TOF-3D MRA clearly reveals bilateral occlusion of internal carotid
arteries and moyamoya vessel formation. (B) DSA image from 2015.
doi:10.1371/journal.pone.0164759.g003
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II-3, and II-4 in Family 1) revealed the wild-type genotype of p.V4146A, and haplotype map-
ping using microsatellite genetic markers around p.V4146A confirmed parentages and sibling-
ship. Taken together, these data indicate that the mutation is a de novomutation. II-1 from
Family 2 harbored two RNF213 rare variants, including p.R4019C (C>T), which was previ-
ously found in white MMD patients [8], and the novel p.E4042K (G>A) variant. Haplotype
analysis by cloning showed that these two mutations occurred on a single allele (Fig 1C). In
Family 3, p.W4677L (G>T) was found in proband (III-2) and the affectedmother (II-2). Gen-
otyping of p.W4677L in five unaffected (I-1, I-2, I-3, II-1, and III-1) members showed segrega-
tion, with exception of I-2.
MAFs of p.V4146A, p.R4019C, and p.E4042K were very rare (< 0.1%), and MAFs of p.
W4677L were 1.49% and 1.86% in two European variant databases (Table 2). P.V4146A, p.
R4019C, and p.W4677L were predicted to be Probably Damaging/Damaging,while p.E4042K
was predicted to be Benign/Tolerated by PolyPhen-2/SIFT, respectively (Table 2). A homology
search indicated conservation of valine at position 4146 and tryptophan at position 4677 of
RNF213 in mammals (Table 3). Arginine at position 4019 was conserved among mammals,
with exception of rodents (Table 3). Conservationof glutamate at position 4042 was observed
in primates (Table 3).
Evaluation of the effects of RNF213 p.D4013N, p.R4019C and p.
V4146A variants on angiogenic activity of vascular endothelial cells
Among the rare variants found in Slovakian and CzechMMD patients (Table 1), p.D4013N, p.
R4019C and p.V4146A are interesting disease-causing variants, because p.D4013N and p.
R4019C was previously identified in white familial MMD cases by our and other groups [4,8]
and p.V4146A is a de novomutation. Furthermore, both pD4013N and p.R4019C are located
in the RING finger domain, which binds E2 and their substrate to function as E3 ligase, while
p.V4146A is outside of this domain (Fig 4). To assess the effect of these variants on angiogenic
activity of vascular endothelial cells (ECs), we performedmigration and tube formation assays
using RNF213mutant-transfected HUVECs [7,9]. Both RNF213D4013N and V4146A signifi-
cantly decreased re-endothelialization in the migration assay compared with RNF213WT and
the control vector (backbone vector not including RNF213) (Fig 5). In the tube formation
assay, HUVECs transfected with RNF213V4146A revealed significantly lower tube area, total
tube length, and numbers of tube branches compared with the RNF213WT and control vector
(Fig 6). RNF213D4013N tended to reduce angiogenesis, although significant differences were
not observed (Fig 6). Migration assay represents capability of cellular migration, and tube for-
mation assay represents the net capability of cell migration, proliferation and survival [10].
Table 2. MAF in database and prediction of functional change of identified RNF213 variants.
Variant rs Number (dbSNP146) MAF (%) in European Variants Database Prediction of Functional
Change
Citation
1000 genome EUR Exome Variant Server European American Polyphen 2 SIFT
p.D4013N rs397514563 0 0 Possibly damaging Tolerated [4, 8]*
p.V4146A (-) 0 0 Probably damaging Damaging
p.R4019C rs139265462 0 0.09 Probably damaging Damaging [8]*
p.E4042K (-) 0 0 Benign Tolerated
p.W4677L rs61741961 1.49 1.86 Probably damaging Damaging
MAF, minor allele frequency
*Previously found in MMD patients
doi:10.1371/journal.pone.0164759.t002
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While RNF213D4013N has a significant inhibitory effect on migration, it does not have a sig-
nificant inhibitory effects on tube formation, suggesting that migration assay is more sensitive
than tube formation assay. It is reported that inhibition of endothelial NO synthase, which is
considered to maintain integrin through NO production, attenuated ECmigration in vitro
Table 3. Homology of identified RNF213 variants.
Species Amino Acid sequence
p.V4146A p.R4019C
Homo sapiens Y S F H D V K D Y I Q H V H C L R C L R A W
Pan troglodytes Y S F H D V K D Y I Q H V H C L R C L R A W
Gorilla gorilla gorilla Y S F H D V K D Y I Q H V H C L R C L R A W
Pongo abelii Y S F N D V K D Y I Q H V H C L R C L R A W
Bos taurus Y S F H D V K E Y I Q H I F C L R C I E V H
Ovis aries Y S F C D V K E Y I Q H V F C L R C I Q V N
Rattus norvegicus Y S F H E V K G Y I Q H V Y C L P C I Q T W
Mus musculus Y S F H E V K D Y I Q H V Y C L P C I Q T W
Species Amino Acid sequence
p.E4042K p.W4677L
Homo sapiens T A L P D E F S P A V E M R N N W E K E I A
Pan troglodytes T A L P D E F S P A V E M R N N W E K E I A
Gorilla gorilla gorilla T A L P D E F S P A V E M R N N W E K E I A
Pongo abelii T A L P D E F S P A V E M R N N W E K E I A
Bos taurus T N L P N T F S P T V E E R N R W E K L V E
Ovis aries T D L P D R Y S P T V E E R N R W E K L V E
Rattus norvegicus T A L P D E F S P T A G C R N N W E K H F G
Mus musculus T D L P D K F S P T V G C R N N W E K H F E
doi:10.1371/journal.pone.0164759.t003
Fig 4. Schematic diagram of RNF213 rare variants identified in MMD patients. Variants in Asian and white patients are
shown above and below the protein, respectively. The five variants identified in MMD patients from this study are shown in
bold characters. AA, amino acid; AAA+, ATPase associated with diverse cellular activities domain; RING, RING-finger
domain. This figure was modified from the original version described in Reference 6.
doi:10.1371/journal.pone.0164759.g004
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[11]. Thus, we postulate that RNF213D4013Nmight predominantly affect ECmigration
through integrinmaintenance by inhibition of NO production. To investigate whether the
mutation in the RING finger domain may impair cell migration, we further evaluated migra-
tion for HUVECs transfected with RNF213R4019C. As expected, it did inhibit migration sig-
nificantly (Fig 5).
Fig 5. Migration assay using HUVECs transfected with RNF213 D4013N, R4019C and V4146A. Representative images
are shown in upper panel. The re-endothelialized areas were quantified by imaging analysis (lower panel). “Vector” represents
backbone vector, not including RNF213. Data with bars represent mean ± SD (n = 3 or 4). *P < 0.05 compared with vector,
#P < 0.05 compared with WT according to Student’s t-test.
doi:10.1371/journal.pone.0164759.g005
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Fig 6. Tube formation assay of HUVECs transfected with RNF213 D4013N and V4146A.
Representative images are shown in upper panel. The tube areas, total tube length, and number of tube
branches were quantified by imaging analysis (lower panel). “Vector” represents backbone vector, not
including RNF213. Data with bars represent mean ± SD (n = 3). *P < 0.05 compared with vector, #P < 0.05
compared with WT, †P < 0.05 compared with D4013N according to Student’s t-test.
doi:10.1371/journal.pone.0164759.g006
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Discussion
In the present study, we identified four rare variants, p.V4146A, p.R4019C, p.E4042K, and
W4677L, in four Slovakian or Czech patients with MMD. P.V4146A was demonstrated to be a
de novomutation, which had not been previously reported. The case harboring p.V4146A was
the third reportedMMD case with a de novomutation; the previous described variants were p.
K4115del [8] and p.S4118F [12]. Double mutations, p.R4019C and p.E4042K, were also identi-
fied in the present study. Although P.E4042K was novel, p.R4019C was previously identified by
screening as a single mutation in white MMD patients [8]. Interestingly, these two mutations
were inherited on the same allele, suggesting that p.E4042K in the present case was likely a
recurrent mutation. Functional predictions (Polyphen 2 and SIFT) showed that p.R4019C was
more deleterious than p.E4042K. These results suggest that p.R4019C might play an essential
role in MMD onset compared to p.E4042K as previously reported in a white MMD patient [8].
Another variant, p.W4677L was detected in two patients and one non-affectedmember in the
pedigree. Furthermore, this is a rare single nucleotide polymorphism (SNP) (MAF; 1.49–
1.86%) in the general European population. These observations indicated relatively low pene-
trance of p.W4677L. Two recent reports demonstrated that interferons overproduced under
inflammatory conditions, such as infection and autoimmune disorders, induced highly up-reg-
ulated RNF213 in ECs [7,13]. Further experimental and epidemiological studies that focus on
the link between infectious and autoimmune disease and RNF213 variants with low penetrance
such as p.W4677L are needed.
Functional analysis of p.D4013N, which was previously identified in a CzechMMD family
[4], p.R4019C and p.V4146A revealed that these RNF213 variants induced inhibited angiogen-
esis in ECs. This lower angiogenesis phenotype was reported to be caused by RNF213 p.
R4810K [7,9], indicating that p.D4013N, p.R4019C and p.V4146A are the likely causative
mutations for MMD. The present study is the first to reveal the inhibitory effects of non-p.
R4810K RNF213 variants on angiogenesis. Furthermore, these results strongly support the con-
cept that reduced angiogenesis plays an important role in MMD etiology.
The RNF213 protein harbors two AAA+ and one RING-finger domain, which have been
demonstrated to exhibit ATPase and E3 activity, respectively [4,14]. The RNF213 rare variants
identified in the present study were located on the locus corresponding to the region from the
RING-finger domain to the C-terminus of the RNF213 protein. This was consistent with char-
acteristics previously described in RNF213 rare variants in Asian and white MMD patients (Fig
4) [6]. It should be noted that p.D4013N, p.R4019C, and E4042K are located in the RING-fin-
ger domain, and these mutations could alter angiogenic activity through E3 ligase activity. In
the present study, we found that mutations (p.D4013N and p.R4019C) in this domain
decreased re-endothelialization, which is associated with integrin homeostasis and NO produc-
tion [11]. We postulated that effects of mutations in the RING finger domain on net angiogen-
esis are milder than p.V4146 or p.R4810K [7] because those mutations could be recoverable in
the tube formation. Further study is needed to confirm our finding.
Genetic epidemiological studies have demonstrated that RNF213 p.R4810K is frequently
observed in East Asian MMD patients (Japan and Korea, 80–90%; China, around 20%) and
was demonstrated to have a strong association with the disease [6]. Our present screening
for RNF213 revealed non-R4810K RNF213 rare variants in 22.2% (4/18 probands) of Slova-
kian or CzechMMD probands (Table 1), raising the possibility that RNF213-associated
MMDmay be present in a relatively large population of non-Asian MMD cases. This concept
was supported by a recent report showing a relatively high frequency of non-R4810K
RNF213 rare variants (10.6% (10/94 probands)) in non-Asian MMD patients from North
America [8].
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Conclusions
The present study suggests that RNF213may also be a major causative gene in a relative large
population of white patients. Routine screening should be performed for RNF213 rare variants
in MMD patients regardless of ethnic background. This could be useful for a definitiveMMD
diagnosis and also serve to provide a better understanding of MMD etiology.
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